Found 223 matching trials
Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH PHASE2 A randomized, multi-center study evaluating MET409 (50 mg) alone or in comb...
Show More Location
Metacrine Investigative Site
Learn More & Join Trial
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) PHASE3 Comparison of 2 doses of empagliflozin vs placebo in patients already using...
Show More Location
AMCR Institute, Inc.
Learn More & Join Trial
Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study PHASE2 Syndrome of inappropriate antidiuresis (SIADH) is characterized by an imbal...
Show More Location
University Hospital Basel
Learn More & Join Trial
Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension PHASE2 Primary Objective:
To compare the metabolic and gastrointestinal pharmacod...
Show More Location
Investigational Site Number 2760001
Learn More & Join Trial
Empagliflozin and Hepatic Glucose Metabolism PHASE4 the aim of this study is to examine the role of autonomic nervous system in...
Show More Location
Diabetes Division, UTHSCSA
Learn More & Join Trial
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease PHASE2 Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage...
Show More Location
Multiple Locations
Learn More & Join Trial
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy PHASE1 The aim of the study is to investigate the possible protective effect of em...
Show More Location
Faculty of pharmacy
Learn More & Join Trial
Empagliflozin and Cardiac Remodelling in People Without Diabetes PHASE4 The purpose of this study is to evaluate the effects of empagliflozin on ca...
Show More Location
Diagnostic Assessment Centre (AMS Diagnostics)
Learn More & Join Trial
BI 10773 add-on to Metformin in Patients With Type 2 Diabetes PHASE2 The objective of the current study is to investigate the efficacy, safety a...
Show More Location
1245.10.10026 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart PHASE3 This study is open to adults with chronic heart failure (HF) who have a red...
Show More Location
Cure Clinical Research
Learn More & Join Trial